Arteriosclerosis, Thrombosis, and Vascular Biology. (n.d.-a). https://www.ahajournals.org/doi/full/10.1161/ATVBAHA.119.311996?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Arteriosclerosis, Thrombosis, and Vascular Biology. (n.d.-b). https://www.ahajournals.org/doi/full/10.1161/ATVBAHA.110.207480
Circulation Research. (n.d.-a). https://www.ahajournals.org/doi/full/10.1161/01.RES.0000252802.25497.b7
Circulation Research. (n.d.-b). https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.116.309692
Circulation Research. (n.d.-c). https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.116.308537
Circulation Research. (n.d.-d). https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.117.312465
De Backer, D., & Dorman, T. (2017). Surviving Sepsis Guidelines. JAMA, 317(8). https://doi.org/10.1001/jama.2017.0059
Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program* | Ovid. (2014). http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00003246&LSLINK=80&D=jbi
Evans, L. (2019). A Closer Look at Sepsis-Associated Mortality. JAMA Network Open, 2(2). https://doi.org/10.1001/jamanetworkopen.2018.7565
Frangogiannis, N. G. (2019). Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. Molecular Aspects of Medicine, 65, 70–99. https://doi.org/10.1016/j.mam.2018.07.001
Hafiane, A., & Daskalopoulou, S. S. (2018). Extracellular vesicles characteristics and emerging roles in atherosclerotic cardiovascular disease. Metabolism, 85, 213–222. https://doi.org/10.1016/j.metabol.2018.04.008
Howell, M. D., & Davis, A. M. (2017). Management of Sepsis and Septic Shock. JAMA, 317(8). https://doi.org/10.1001/jama.2017.0131
Huang, S., & Frangogiannis, N. G. (2018). Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges. British Journal of Pharmacology, 175(9), 1377–1400. https://doi.org/10.1111/bph.14155
Knaus, W. A., & Marks, R. D. (2019). New Phenotypes for Sepsis. JAMA, 321(20). https://doi.org/10.1001/jama.2019.5794
Komorowski, M., Celi, L. A., Badawi, O., Gordon, A. C., & Faisal, A. A. (2018). The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care. Nature Medicine, 24(11), 1716–1720. https://doi.org/10.1038/s41591-018-0213-5
McPherson, D., Griffiths, C., Williams, M., Baker, A., Klodawski, E., Jacobson, B., & Donaldson, L. (2013). Sepsis-associated mortality in England: an analysis of multiple cause of death data from 2001 to 2010. BMJ Open, 3(8). https://doi.org/10.1136/bmjopen-2013-002586
Norman, D. C. (2000). Fever in the Elderly. Clinical Infectious Diseases, 31(1), 148–151. https://doi.org/10.1086/313896
Rhee, C., Jones, T. M., Hamad, Y., Pande, A., Varon, J., O’Brien, C., Anderson, D. J., Warren, D. K., Dantes, R. B., Epstein, L., & Klompas, M. (2019). Prevalence, Underlying Causes, and Preventability of Sepsis-Associated Mortality in US Acute Care Hospitals. JAMA Network Open, 2(2). https://doi.org/10.1001/jamanetworkopen.2018.7571
Seymour, C. W., Kennedy, J. N., Wang, S., Chang, C.-C. H., Elliott, C. F., Xu, Z., Berry, S., Clermont, G., Cooper, G., Gomez, H., Huang, D. T., Kellum, J. A., Mi, Q., Opal, S. M., Talisa, V., van der Poll, T., Visweswaran, S., Vodovotz, Y., Weiss, J. C., … Angus, D. C. (2019). Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA, 321(20). https://doi.org/10.1001/jama.2019.5791
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., Hotchkiss, R. S., Levy, M. M., Marshall, J. C., Martin, G. S., Opal, S. M., Rubenfeld, G. D., van der Poll, T., Vincent, J.-L., & Angus, D. C. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8). https://doi.org/10.1001/jama.2016.0287
Sund-Levander, M., Forsberg, C., & Wahren, L. K. (2002). Normal oral, rectal, tympanic and axillary body temperature in adult men and women: a systematic literature review. Scandinavian Journal of Caring Sciences, 16(2), 122–128. https://doi.org/10.1046/j.1471-6712.2002.00069.x
Westman, P. C., Lipinski, M. J., Luger, D., Waksman, R., Bonow, R. O., Wu, E., & Epstein, S. E. (2016). Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction. Journal of the American College of Cardiology, 67(17), 2050–2060. https://doi.org/10.1016/j.jacc.2016.01.073
Wick, G., & Grundtman, C. (Eds.). (2012). Inflammation and Atherosclerosis. Springer Vienna. https://doi.org/10.1007/978-3-7091-0338-8
Zhou, S., Jin, J., Wang, J., Zhang, Z., Freedman, J. H., Zheng, Y., & Cai, L. (2018). miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Acta Pharmacologica Sinica, 39(7), 1073–1084. https://doi.org/10.1038/aps.2018.30